Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) study protocol: a multiregional, cross-sectional analysis of maternal immunization delivery strategies to reduce maternal and neonatal morbidity and mortality
IntroductionMaternal immunization (MI) with tetanus toxoid containing vaccine, is a safe and cost-effective way of preventing neonatal tetanus. Given the prospect of introducing new maternal vaccines in the near future, it is essential to identify and understand current policies, practices and unmet...
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2019-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/9/6/e024449.full |
id |
doaj-97c1210d553f4bcf978a0aa756aaea13 |
---|---|
record_format |
Article |
spelling |
doaj-97c1210d553f4bcf978a0aa756aaea132021-07-03T12:32:12ZengBMJ Publishing GroupBMJ Open2044-60552019-06-019610.1136/bmjopen-2018-024449Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) study protocol: a multiregional, cross-sectional analysis of maternal immunization delivery strategies to reduce maternal and neonatal morbidity and mortalityTheresa Diaz0Pradeep HaldarNathalie Roos1Philipp Lambach2Carsten Mantel3Elizabeth Mason4Flor M Muñoz5Michelle Giles6Allisyn Moran7Joachim Hombach8Michelle L GilesMercy AhunMartina BayeMatthews Mathai9Sonja MertensJayani PathiranaSarah RendellEmily WoottonLaura Nic Lochlainn10Ahmadu YakubuAnd Sara Rendell1 Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland 1 Department of Maternal Newborn Child and Adolescent Health (MCA), Epidemiology Monitoring and Evaluation (EME), World Health Organization, Geneva, Switzerland 2 Department of Immunization, Vaccines and Biologicals (IVB), Initiative for Vaccine Research (IVR), World Health Organization, Geneva, Switzerland3 Independant consulting and advisory group, MMGH Consulting GmbH, Zürich, Switzerland 5 Faculty of epidemiology and population health, Department of infectious disease epidemiology, London School of Hygiene and Tropical Medicine, London, UK 6 Department of Pediatrics, Section of Infectious Diseases, Baylor College of Medicine, Houston, Texas, USA7 Department of Obstetrics and Gynaecology, Monash University and Monash Health, Melbourne, Australia 1 Department of Maternal Newborn Child and Adolescent Health (MCA), Epidemiology Monitoring and Evaluation (EME), World Health Organization, Geneva, Switzerland2 Department of Immunization, Vaccines and Biologicals (IVB), Initiative for Vaccine Research (IVR), World Health Organization, Geneva, SwitzerlandDepartment of International Public Health, Centre for Maternal and Newborn Health, Liverpool School of Tropical Medicine, Liverpool, UK1Health Service Executive Health Protection Surveillance Centre (HPSC), Dublin, IrelandIntroductionMaternal immunization (MI) with tetanus toxoid containing vaccine, is a safe and cost-effective way of preventing neonatal tetanus. Given the prospect of introducing new maternal vaccines in the near future, it is essential to identify and understand current policies, practices and unmet needs for introducing and/or scaling up MI in low-income and middle-income countries (LMICs).Methods and analysisThe Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) is a mixed methods, cross-sectional study that will collect data in four phases: (1) a review of global databases for selected health indicators in 136 LMICs; (2) a structured online survey directed at Maternal, Newborn and Child Health and Expanded Programme on Immunization focal points in all 136 LMICs; (3) semistructured telephone interviews of 30 selected LMICs and (4) 10 week-long country visits, including key informant interviews, health facility visits and focus group discussions. The principal analyses will assess correlations between the various aspects of MI delivery strategies and proxy measures of health systems performance related to vaccine-preventable disease control. The primary outcome will be a typology of existing MI delivery models, and secondary outcomes will include country profiles of child and maternal health indicators, and a MI gaps and needs analysis.Ethics and disseminationThe protocol was approved by the WHO Ethics Review Committee (ERC.0002908). The results will be made available in a project report and submitted for publication in peer-reviewed journals that will be shared broadly among global health decision-makers, researchers, product developers and country-level stakeholders.https://bmjopen.bmj.com/content/9/6/e024449.full |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Theresa Diaz Pradeep Haldar Nathalie Roos Philipp Lambach Carsten Mantel Elizabeth Mason Flor M Muñoz Michelle Giles Allisyn Moran Joachim Hombach Michelle L Giles Mercy Ahun Martina Baye Matthews Mathai Sonja Mertens Jayani Pathirana Sarah Rendell Emily Wootton Laura Nic Lochlainn Ahmadu Yakubu And Sara Rendell |
spellingShingle |
Theresa Diaz Pradeep Haldar Nathalie Roos Philipp Lambach Carsten Mantel Elizabeth Mason Flor M Muñoz Michelle Giles Allisyn Moran Joachim Hombach Michelle L Giles Mercy Ahun Martina Baye Matthews Mathai Sonja Mertens Jayani Pathirana Sarah Rendell Emily Wootton Laura Nic Lochlainn Ahmadu Yakubu And Sara Rendell Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) study protocol: a multiregional, cross-sectional analysis of maternal immunization delivery strategies to reduce maternal and neonatal morbidity and mortality BMJ Open |
author_facet |
Theresa Diaz Pradeep Haldar Nathalie Roos Philipp Lambach Carsten Mantel Elizabeth Mason Flor M Muñoz Michelle Giles Allisyn Moran Joachim Hombach Michelle L Giles Mercy Ahun Martina Baye Matthews Mathai Sonja Mertens Jayani Pathirana Sarah Rendell Emily Wootton Laura Nic Lochlainn Ahmadu Yakubu And Sara Rendell |
author_sort |
Theresa Diaz |
title |
Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) study protocol: a multiregional, cross-sectional analysis of maternal immunization delivery strategies to reduce maternal and neonatal morbidity and mortality |
title_short |
Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) study protocol: a multiregional, cross-sectional analysis of maternal immunization delivery strategies to reduce maternal and neonatal morbidity and mortality |
title_full |
Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) study protocol: a multiregional, cross-sectional analysis of maternal immunization delivery strategies to reduce maternal and neonatal morbidity and mortality |
title_fullStr |
Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) study protocol: a multiregional, cross-sectional analysis of maternal immunization delivery strategies to reduce maternal and neonatal morbidity and mortality |
title_full_unstemmed |
Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) study protocol: a multiregional, cross-sectional analysis of maternal immunization delivery strategies to reduce maternal and neonatal morbidity and mortality |
title_sort |
maternal immunization and antenatal care situation analysis (miacsa) study protocol: a multiregional, cross-sectional analysis of maternal immunization delivery strategies to reduce maternal and neonatal morbidity and mortality |
publisher |
BMJ Publishing Group |
series |
BMJ Open |
issn |
2044-6055 |
publishDate |
2019-06-01 |
description |
IntroductionMaternal immunization (MI) with tetanus toxoid containing vaccine, is a safe and cost-effective way of preventing neonatal tetanus. Given the prospect of introducing new maternal vaccines in the near future, it is essential to identify and understand current policies, practices and unmet needs for introducing and/or scaling up MI in low-income and middle-income countries (LMICs).Methods and analysisThe Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) is a mixed methods, cross-sectional study that will collect data in four phases: (1) a review of global databases for selected health indicators in 136 LMICs; (2) a structured online survey directed at Maternal, Newborn and Child Health and Expanded Programme on Immunization focal points in all 136 LMICs; (3) semistructured telephone interviews of 30 selected LMICs and (4) 10 week-long country visits, including key informant interviews, health facility visits and focus group discussions. The principal analyses will assess correlations between the various aspects of MI delivery strategies and proxy measures of health systems performance related to vaccine-preventable disease control. The primary outcome will be a typology of existing MI delivery models, and secondary outcomes will include country profiles of child and maternal health indicators, and a MI gaps and needs analysis.Ethics and disseminationThe protocol was approved by the WHO Ethics Review Committee (ERC.0002908). The results will be made available in a project report and submitted for publication in peer-reviewed journals that will be shared broadly among global health decision-makers, researchers, product developers and country-level stakeholders. |
url |
https://bmjopen.bmj.com/content/9/6/e024449.full |
work_keys_str_mv |
AT theresadiaz maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT pradeephaldar maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT nathalieroos maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT philipplambach maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT carstenmantel maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT elizabethmason maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT flormmunoz maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT michellegiles maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT allisynmoran maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT joachimhombach maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT michellelgiles maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT mercyahun maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT martinabaye maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT matthewsmathai maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT sonjamertens maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT jayanipathirana maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT sarahrendell maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT emilywootton maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT lauraniclochlainn maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT ahmaduyakubu maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality AT andsararendell maternalimmunizationandantenatalcaresituationanalysismiacsastudyprotocolamultiregionalcrosssectionalanalysisofmaternalimmunizationdeliverystrategiestoreducematernalandneonatalmorbidityandmortality |
_version_ |
1721320982830907392 |